Aveanna Healthcare Holdings Inc AVAH.OQ AVAH.O is expected to show a rise in quarterly revenue when it reports results on November 7 for the period ending September 30 2024
The Atlanta Georgia-based company is expected to report a 3.8% increase in revenue to $496.02 million from $478.01 million a year ago, according to the mean estimate from 7 analysts, based on LSEG data.
LSEG's mean analyst estimate for Aveanna Healthcare Holdings Inc is for a loss of 1 cent per share.
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 5 "hold" and 2 "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Aveanna Healthcare Holdings Inc is 5.00, above its last closing price of $4.63.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Jun. 30 2024 | -0.01 | -0.02 | 0.01 | Beat | 150 |
Mar. 31 2024 | -0.05 | -0.05 | -0.03 | Beat | 36.8 |
Dec. 31 2023 | -0.02 | -0.02 | -0.02 | Met | 15.8 |
Sep. 30 2023 | -0.03 | -0.03 | -0.03 | Met | -12.5 |
Jun. 30 2023 | -0.04 | -0.04 | -0.02 | Beat | 44.8 |
Mar. 31 2023 | -0.06 | -0.06 | -0.05 | Beat | 18.6 |
Jan. 1 0001 | -0.01 | -0.02 | -0.03 | Missed | -81 |
Sep. 30 2022 | 0.03 | 0.04 | -0.03 | Missed | -185.7 |
This summary was machine generated November 6 at 14:17 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。